Validation of a visual analogue symptom score - the LRTI (lower respiratory tract infections)-VAS- in non-CF bronchiectasis
Completed
- Conditions
- Irriversible dilatation of the large en medium-size airways.10006436
- Registration Number
- NL-OMON34926
- Lead Sponsor
- Medisch Centrum Alkmaar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Part 1:
- Bronchiectasis confirmed by HRCT
- Spirometry (FEV1, FVC) < 6 months ago
- No infective exacerbation < 1 month before study entry
- Ability to read and write
- Informed consent. ;Part 2:
Bronchiectasis confirmed by HRCT
Spirometry (FEV1, FVC) < 6 months ago
Infective exacerbation of bronchiectasis (PDE or NPDE (see below) for which a course of
oral or iv-antibiotics is prescribed.
Ability to read and write
Informed consent.
Exclusion Criteria
- Illiteracy or psychological incapacity to complete a standard questionnaire.
- No informed consent
- Cystic fibrosis
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The results of the 4 questionnaires, correlated to lung function and arterial<br /><br>ogygen saturation.<br /><br>Validity, responsiveness en stability of the VAS-score. </p><br>
- Secondary Outcome Measures
Name Time Method <p>nvt</p><br>